Literature DB >> 22133356

Pneumocystis jiroveci Pneumonia in an Atypical Host.

Raquel E Reinbolt1, Shadia Alam, Rachel Layman, Charles Shapiro, Maryam Lustberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22133356      PMCID： PMC3498486          DOI： 10.1016/j.clbc.2011.10.003

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  22 in total

1.  Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours.

Authors:  P Schöffski; T Hagedorn; V Grünwald; H Paul; K Merkle; R Kowalski; A Ganser
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

2.  Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma.

Authors:  M W Brunvand; C Collins; R B Livingston; G Raghu
Journal:  Cancer       Date:  1991-05-01       Impact factor: 6.860

3.  Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.

Authors:  N G Mansharamani; D Balachandran; I Vernovsky; R Garland; H Koziel
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

4.  Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.

Authors:  David M Peereboom; Dale R Shepard; Manmeet S Ahluwalia; Cathy J Brewer; Neeraj Agarwal; Glen H J Stevens; John H Suh; Steven A Toms; Michael A Vogelbaum; Robert J Weil; Paul Elson; Gene H Barnett
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

Review 5.  Pneumocystis carinii pneumonia in patients without AIDS.

Authors:  K A Sepkowitz
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

6.  Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer.

Authors:  A Klippstein; C P Schneider; H G Sayer; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-17       Impact factor: 4.553

7.  Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; G K Rivera; M J Schell; D Thornton; L Lott
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

8.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

9.  Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia.

Authors:  W G Woods; A E Daigle; R J Hutchinson; L L Robison
Journal:  J Pediatr       Date:  1984-10       Impact factor: 4.406

10.  Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors.

Authors:  Anuj K Mahindra; Stuart A Grossman
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.506
View more
  4 in total

1.  A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma.

Authors:  Jeonghoon Ha; Yunhwa Jung; Yunduk Jung; Sanbin Lee; Yoonseo Lee; Insook Woo
Journal:  Blood Res       Date:  2016-03-25

Review 2.  Bendamustine and pneumocystis pneumonia: A systematic review.

Authors:  Atousa Hakamifard; Masoud Mardani; Mohammad Javad Nasiri; Tahereh Gholipur-Shahraki
Journal:  Health Sci Rep       Date:  2022-04-26

3.  Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol.

Authors:  Tarig Mohammed Abkur; Mamoun Saeed; Saad Zeinalabdin Ahmed; Ryan McArthur; Maeve Leahy; Hilary O'Leary; Denis O'Keeffe
Journal:  Clin Case Rep       Date:  2015-02-09

4.  Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.

Authors:  Mikhaila L Rice; Jason N Barreto; Carrie A Thompson; Kristin C Mara; Pritish K Tosh; Andrew H Limper
Journal:  Cancer Med       Date:  2021-06-22       Impact factor: 4.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.